Company profile
Viking Therapeutics, Inc. Insider Trading
VKTXEvery SEC Form 4 insider trading filing for Viking Therapeutics, Inc. (VKTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001607678
- Filings
- 83
- Insiders
- 11
- Last filing
- 2026-08-01
Activity summary
No insider transactions in the last 30 days. The most recent was on August 1, 2026, when Dorothy Elizabeth Kelly-Gemmell bought 6,333 shares. 83 filings from 11 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Viking Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $52.5M.
90 day insight
Over the last 90 days, Viking Therapeutics, Inc. insiders bought $0 (5 transactions) and sold $6.3M (3 transactions).
- Most active insider: Brian Lian with 2 transactions totaling $4.9M.
- Largest single sale: $4.9M by Brian Lian on Jul 29, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | Dorothy Elizabeth Kelly-Gemmell | VKTX | Award | 6,333 | — | — |
| Aug 1, 2026 | Dorothy Elizabeth Kelly-Gemmell | VKTX | Award | 40,800 | — | — |
| Jul 29, 2026 | Marianna Mancini | VKTX | Sale | 18,217 | $33.47 | $610K |
| Jul 29, 2026 | Greg Zante | VKTX | Sale | 21,217 | $33.47 | $710K |
| Jul 29, 2026 | Brian Lian | VKTX | Sale | 148,517 | $33.32 | $4.95M |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=VKTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Viking Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →